Citigroup
AEON icon

Citigroup’s AEON Biopharma AEON Stock Holding History

Citigroup’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.26K Buy
7,315
+6,573
+886% +$5.5K ﹤0.01% 5304
2026
Q1 		$731 Buy
+742
New +$829 ﹤0.01% 5507
2025
Q3 		– Sell
-272
Closed -$207 – 6054
2025
Q2 		$207 Buy
+272
New +$156 ﹤0.01% 5478
2022
Q3 		– Sell
-347
Closed -$245K – 5781
2022
Q2 		$245K Hold
347
– – ﹤0.01% 3729
2022
Q1 		$245K Hold
347
– – ﹤0.01% 3959
2021
Q4 		$243K Buy
+347
New +$244K ﹤0.01% 4250

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup's AEON Position: Q2 2026 in Review

Citigroup increased its AEON Biopharma (AEON) stake by 886% in Q2 2026, buying an estimated $5.5K and bringing the position to 7,315 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #5304.

Citigroup first reported a position in AEON in Q4 2021 and has held it in 6 quarters since. The position peaked at $245K in Q2 2022. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Citigroup held 7,315 shares of AEON Biopharma worth $5.26K as of Q2 2026.
  • Citigroup bought 6,573 AEON Biopharma shares in Q2 2026, an estimated $5.5K.
  • AEON Biopharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5304 holding.
  • Citigroup first reported a position in AEON Biopharma in Q4 2021 and has held it in 6 quarters since.
  • Citigroup's AEON Biopharma position peaked at $245K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.